Skip to main content
TipRanks
Go Ultimate75% OFF

Tci Gene Inc. (6879) Financial Statements

Tci Gene Inc. Financial Overview

Tci Gene Inc.'s market cap is currently NT$939.28M. The company's EPS TTM is NT$1.92; its P/E ratio is 18.49; and it has a dividend yield of 5.63%. Tci Gene Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 273.61MNT$ 347.54MNT$ 333.86MNT$ 424.02MNT$ 432.22M
Gross ProfitNT$ 152.59MNT$ 204.07MNT$ 174.62MNT$ 243.36MNT$ 239.43M
Operating IncomeNT$ 20.93MNT$ 52.50MNT$ 5.93MNT$ 90.56MNT$ 113.57M
EBITDANT$ 32.91MNT$ 81.85MNT$ 25.89MNT$ 121.16MNT$ 155.43M
Net IncomeNT$ 40.57MNT$ 56.31MNT$ 11.67MNT$ 72.14MNT$ 92.45M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 831.73MNT$ 836.93MNT$ 899.65MNT$ 937.74MNT$ 330.19M
Total AssetsNT$ 1.01BNT$ 1.10BNT$ 1.17BNT$ 1.16BNT$ 560.31M
Total DebtNT$ 7.10MNT$ 775.00KNT$ 6.79MNT$ 2.47MNT$ 8.27M
Net DebtNT$ -243.59MNT$ -97.65MNT$ -689.25MNT$ -930.26MNT$ -317.92M
Total LiabilitiesNT$ 98.64MNT$ 101.29MNT$ 155.55MNT$ 143.17MNT$ 169.44M
Stockholders' EquityNT$ 890.51MNT$ 974.73MNT$ 986.51MNT$ 1.01BNT$ 380.20M
Cash Flow
Free Cash FlowNT$ 150.91MNT$ 54.30MNT$ 14.68MNT$ 95.06MNT$ 95.76M
Operating Cash FlowNT$ 151.33MNT$ 56.97MNT$ 17.85MNT$ 110.35MNT$ 119.18M
Investing Cash FlowNT$ 59.68MNT$ -619.34MNT$ -203.86MNT$ -39.99MNT$ -26.95M
Financing Cash FlowNT$ -59.83MNT$ -35.52MNT$ -50.64MNT$ 535.73MNT$ 54.61M

Currency in TWD

Tci Gene Inc. Earnings and Revenue History

0200M400M600M0 %12 %24 %36 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

Tci Gene Inc. Liabilities to Assets

0500M1B1.5B0 %12 %24 %36 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Tci Gene Inc. Cash Flow

-750M-500M-250M0250M500M750M2019202020212022202320242025OperatingInvestingFinancing

Tci Gene Inc. Forecast EPS vs Actual EPS